Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)

Mayer Rokitansky Kuster Hauser Syndrome Clinical Trial

Official title: Feasibility Study of Uterine Transplantation From Living Donors in Terms of Efficacy and Safety in Patients With Mayer-Rokitansky-Küster-Hauser Syndrome (MRKH)

Status Recruiting

Clinical Trial Summary

In France, one in 4500 women is affected by the MayerRokitantskyKüsterHauser (MRKH) syndrome which is characterized by the absence of uterus at birth. Currently, the only solutions for these patients are: - Gestational surrogacy, prohibited in France - Adoption - Resignation Uterine transplantation could become a good alternative. This study is conducted in 10 patients with MRKH type I syndrome, who will be transplanted from a living donor uterus

Clinical Trial Description

The aim of the study is to obtain a pregnancy after uterine transplantation from a living donor. Also, this study will assess (anatomically and functionally) the issue of the transplants of a uterus taken from a living donor and the safety of the living donor (functionally and psychologically) ;

Related Conditions & MeSH terms

• Mayer Rokitansky Kuster Hauser Syndrome
• Syndrome

• NCT number: NCT03689842
• Study type: Interventional
• Source: Hopital Foch
• Status: Recruiting
• Phase: N/A
• Start date: December 14, 2017
• Completion date: June 1, 2025